Results 41 to 50 of about 3,215 (175)

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Dydrogesterone use in early pregnancy

Gynecological Endocrinology, 2016
Successful oocyte implantation and a favorable pregnancy outcome rely on optimal progesterone levels. Therefore, progesterone deficiencies associated with infertility and miscarriage have commonly been treated with progestogens that mimic the activity of progesterone.
Mirza, Fadi Ghazi, Patki, Ameet, Pexman-Fieth, Claire   +2 more
openaire   +3 more sources

The effect of dydrogesterone on sexual function in endometriosis

Journal of Obstetrics and Gynaecology, 2021
Endometriosis is an oestrogen-dependent chronic disease, which is commonly regarded as a disease of reproductive-aged women. We aimed to evaluate the sexual function with Female Sexual Function Index (FSFI) in women with endometriosis who received dydrogesterone for 6 months.
Pınar Yalçın Bahat, Burak Yücel, Bahar Yuksel Ozgor, Pınar Kadiroğulları, Nura Fitnat Topbas Selçuki, Kübra Çakmak, Eda Üreyen Özdemir   +6 more
openaire   +2 more sources

Curcumin Attenuates Decidual Stromal Cell Ferroptosis and Restores Impaired Decidualization in Recurrent Spontaneous Abortion by Targeting BRD4

Food Science &Nutrition, Volume 14, Issue 8, August 2026.
Curcumin attenuates decidual ferroptosis and restores decidualization by targeting BRD4 in RSA. ABSTRACT Recurrent spontaneous abortion (RSA) is a major reproductive health challenge with limited clinical options. Curcumin, a natural polyphenol widely consumed as a dietary supplement, has shown promise in improving pregnancy outcomes; however, its ...
Yiming Ma, Weiping Chen, Tian Xie, Yueling Wu, Yangyang Xing, Xiaoxuan Zhao, Jialin He   +6 more
wiley   +1 more source

A successful in vitro fertilization outcome in a hermaphrodite male

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 424-425, April 2025.
Shima Elbakhit M. E. Albasha, Sami Saadi Al‐Said, Haitham Tharwat M. H. El Bardisi   +2 more
wiley   +1 more source

Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1454-1467, August 2026.
In this Swedish register‐based cohort study, systemic menopausal hormone therapy dispensing decreased over 15 years, while local therapy increased. Age, cohort effects, and sociodemographic characteristics were associated with differences in dispensing patterns.
Rebecca Götze Eriksson, Fanny Söderquist, Ge Bai, Per Wikman, Diego Hernan Giunta, Inger Sundström Poromaa, Evangelia Elenis, Angelica Lindén Hirschberg, Alkistis Skalkidou, Stavros I. Iliadis   +9 more
wiley   +1 more source

Open-label, Prospective, Investigator Initiated Study to Assess the Clinical Role of Oral Natural or Synthetic Progesterone During Stimulated IUI Cycles for Unexplained Infertility [PDF]

Journal of Clinical and Diagnostic Research, 2016
Background: Unexplained infertility remains as one of the important subtype of infertility that follows expectant management with Intrauterine Insemination (IUI) in most cases.
Jaideep Malhotra, Korukonda Krishnaprasad   +1 more
doaj   +1 more source

Progestogen supplementation to prevent miscarriage: Evidence and controversies

International Journal of Gynecology &Obstetrics, Volume 174, Issue 1, Page 44-49, July 2026.
Abstract Progesterone plays a key role in the establishment and maintenance of pregnancy and its deficiency has been associated with early pregnancy loss. Progestogen supplementation has therefore been widely investigated as a preventive strategy against miscarriage, particularly in women with recurrent pregnancy loss or threatened miscarriage or after
Gabriele Saccone, Vincenzo Berghella, Moti Gulersen, Attilio Di Spiezio Sardo   +3 more
wiley   +1 more source

Features of early pregnancy treatment in women with luteal phase defect

Гинекология, 2013
The purpose of this study was the first pregnancy trimester flow analysis in patients with IDLF receiving pre-gravidity training including dydrogesterone taking. Materials and methods.
A F Mikhelson, E Yu Lebedenko, T E Feoktistova, M P Kurochka, N B Kuznetsova, S M Nastueva   +5 more
doaj  

No improvement in pregnancy and perinatal outcomes with combined luteal support in modified natural cycle frozen embryo transfer

Frontiers in Endocrinology
ObjectiveWe investigated whether the addition of a luteal phase support drug benefits pregnancy and perinatal outcomes in modified natural-cycle frozen-thawed embryo transfer (mNC-FET) for women up to the age of 35 years.MethodsWe analyzed the clinical ...
Wen Zhang, Sheling Wu, Bingnan Ren, Ruolin Jia, Wenjuan Zhang, Bijun Wang, Xiaofang Du, Yichun Guan   +7 more
doaj   +1 more source